Dexmedetomidine
23-18229
Approved small_molecule active
Quick answer
Dexmedetomidine for Breast Cancer is a Approved program (small_molecule) at United Therapeutics Europe Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- United Therapeutics Europe Ltd
- Indication
- Breast Cancer
- Phase
- Approved
- Modality
- small_molecule
- Status
- active